Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$21.0 - $29.1 $1.55 Million - $2.15 Million
-73,844 Reduced 84.19%
13,867 $307,000
Q4 2023

Feb 14, 2024

SELL
$19.72 - $28.68 $216 - $315
-11 Reduced 0.01%
87,711 $2.41 Million
Q3 2023

Nov 14, 2023

BUY
$22.33 - $29.92 $245 - $329
11 Added 0.01%
87,722 $1.96 Million
Q2 2023

Aug 14, 2023

BUY
$20.96 - $26.99 $187,277 - $241,155
8,935 Added 11.34%
87,711 $2.23 Million
Q1 2023

May 15, 2023

BUY
$20.58 - $27.89 $1.62 Million - $2.2 Million
78,776 New
78,776 $1.76 Million
Q3 2021

Nov 15, 2021

SELL
$35.62 - $52.97 $498,679 - $741,580
-14,000 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$32.94 - $56.62 $2.21 Million - $3.8 Million
-67,057 Reduced 82.73%
14,000 $560,000
Q1 2021

May 17, 2021

BUY
$44.47 - $81.38 $2.97 Million - $5.44 Million
66,808 Added 468.86%
81,057 $4.36 Million
Q4 2020

Feb 16, 2021

BUY
$32.49 - $61.88 $203,614 - $387,801
6,267 Added 78.51%
14,249 $697,000
Q3 2020

Nov 16, 2020

BUY
$26.73 - $35.67 $213,358 - $284,717
7,982 New
7,982 $259,000
Q1 2020

May 15, 2020

SELL
$16.13 - $30.17 $167,752 - $313,768
-10,400 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$20.78 - $29.99 $993,284 - $1.43 Million
-47,800 Reduced 82.13%
10,400 $290,000
Q2 2019

Aug 14, 2019

BUY
$22.1 - $28.56 $594,490 - $768,264
26,900 Added 85.94%
58,200 $1.66 Million
Q1 2019

May 15, 2019

BUY
$12.0 - $25.76 $30,000 - $64,400
2,500 Added 8.68%
31,300 $783,000
Q4 2018

Feb 14, 2019

SELL
$9.15 - $14.85 $118,950 - $193,050
-13,000 Reduced 31.1%
28,800 $362,000
Q3 2018

Nov 14, 2018

SELL
$9.55 - $12.64 $7,210 - $9,543
-755 Reduced 1.77%
41,800 $399,000
Q2 2018

Aug 14, 2018

SELL
$5.39 - $9.66 $30,426 - $54,530
-5,645 Reduced 11.71%
42,555 $397,000
Q1 2018

May 15, 2018

SELL
$5.44 - $6.97 $2,012 - $2,578
-370 Reduced 0.76%
48,200 $268,000
Q4 2017

Feb 14, 2018

BUY
$6.05 - $9.37 $293,848 - $455,100
48,570
48,570 $317,000

Others Institutions Holding VCYT

About VERACYTE, INC.


  • Ticker VCYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,575,904
  • Market Cap $2.42B
  • Description
  • Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...
More about VCYT
Track This Portfolio

Track Pdt Partners, LLC Portfolio

Follow Pdt Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pdt Partners, LLC with notifications on news.